I-DECIDE After Bronchiolitis Hospitalization
ConditionBronchiolitis Acute
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-24
SponsorSeattle Children's Hospital
About this trial
Although automatic follow-up is a nearly universal practice, research has shown that these visits are often unnecessary after hospitalizations caused by bronchiolitis. Despite endorsement by national pediatric authorities, robust evidence, and family enthusiasm for as-needed (PRN) follow-up, it remains substantially underutilized for children hospitalized for bronchiolitis.
The goal of I-DECIDE is to compare the effects of two multi-component implementation strategies, both of which aim to (a) increase PRN follow-up prescribing by hospitalists (physicians who care for hospitalized children) and (b) decrease unnecessary follow-up visit attendance by families.
Eligibility criteria
Qualifiers
Primary diagnosis of bronchiolitis, discharged by a generalist inpatient service from a non-ICU, non-emergency department, non-step down unit
Disqualifiers
Children with a history of gestational age <28 weeks, chronic lung disease, complex or hemodynamically significant heart disease, immunodeficiency, or neuromuscular disease
Children being discharged with home oxygen therapy
Trial design
Treatments tested in this trial
- Moderate-Resource Implementation Strategy
- High-Resource Implementation Strategy
Treatment groups
2,700 Participants
are divided into 2 treatment groupsSponsors and collaborators
Seattle Children's Hospital
Lead sponsor
Patient-Centered Outcomes Research Institute
Collaborator
Children's Hospital of Philadelphia
Collaborator
Source ClinicalTrials.gov